Critical analysis of Parkinson’s disease detection using EEG sub-bands and gated recurrent unit
Parkinson’s disease, the second most common neurodegenerative disorder in the world. A progressive disease, which can worsen over time and lead to complications like mild cognitive impairments and dementia. The accurate diagnosis of Parkinson’s Disease (PD) remains a critical challenge in medical en...
Gespeichert in:
Veröffentlicht in: | Engineering science and technology, an international journal an international journal, 2024-11, Vol.59, p.101855, Article 101855 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Parkinson’s disease, the second most common neurodegenerative disorder in the world. A progressive disease, which can worsen over time and lead to complications like mild cognitive impairments and dementia. The accurate diagnosis of Parkinson’s Disease (PD) remains a critical challenge in medical engineering. This study explores the potential of brain wave patterns for PD detection in healthy and unhealthy patients. The Power Spectral Density (PSD) and proposed PD detection model based on the Gated Recurrent Unit (GRU) is used to analyze brain activities. It was found that the detection of PD in patients was improved by classifying the RAW EEG in conjunction with the sub-bands using PSD as a feature and GRU as a classifier. The performance matrices including accuracy, precision, recall, and F1-score fall within a range of 90% to 98% for alpha, beta, and gamma sub-bands, while the area under the curve in the case of receiver operating characteristics curve achieved the maximum value of 1.00. To assess the differences between the groups with Parkinson’s disease and the healthy group, a statistical significance test was performed. The power spectral density of the two groups differed statistically significantly, according to the results, indicating that they could be useful as biomarkers for the identification of Parkinson’s disease. The results are compared and validated with the standard performance measures. |
---|---|
ISSN: | 2215-0986 2215-0986 |
DOI: | 10.1016/j.jestch.2024.101855 |